Bear Stearns Health Innoventures
Est. dry powder
—
Not reported
AUM
—
Not reported
Latest fund
—
Not reported
Est. cheque size
—
Not reported
Deals, last 12 months
—
Not reported
About Bear Stearns Health Innoventures
Bear Stearns Health Innoventures is a New York-based venture capital firm specialising in early and mid-stage investments. The firm tends to concentrate investment within the biotechnology sector. In 2008, the firm merged with J.P. Morgan Chase & Co.
- Type
- Venture Capital Firm
- Headquarters
- New York, New York, US
- Stages
- Series BSeries CSeries DSeries EEarly Stage
- Regions
- North America
Where they invest
From deals and portfolio companies on record
Most frequent rounds
- Series C6
- Series D4
- Series B1
- Series E1
Across 14 deals
Portfolio sectors
- Pharmaceuticals5
- Biotechnology3
- Software1
Across 9 companies
Portfolio countries
- US9
Across 9 companies
Recent investments
Newest 5 of 14
- Series D$41M
Agensys Inc.
Jul 2007 · Series D
- Series B$45M
Sirion Therapeutics, Inc.
Apr 2007 · Series B
- Series D$35M
TolerRx Inc.
Aug 2006 · Series D
- Series C$35M
Achillion Pharmaceuticals, Inc.
May 2006 · Series C
- Series E$10M
Affymax Inc.
Apr 2006 · Series E
Offices
1 location
- New York, New York, USHQ
Questions about Bear Stearns Health Innoventures
What stages does Bear Stearns Health Innoventures invest in?
Bear Stearns Health Innoventures has invested at Series B, Series C, Series D, Series E and Early Stage. Its most frequent rounds on record are Series C, Series D and Series B.
What has Bear Stearns Health Innoventures invested in recently?
Recent investments include Agensys Inc., Sirion Therapeutics, Inc. and TolerRx Inc..
Where is Bear Stearns Health Innoventures based?
Bear Stearns Health Innoventures is headquartered in New York, US.